🏛️ Verified NIH Record • Updated 2025-09-10
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye (NCT07179055)
An Eight-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye
🟢 Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Vanda Pharmaceuticals
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Who can join: Review the eligibility criteria below.
Location: Vanda Investigational Site — Newport Beach, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- Vanda Investigational Site — Newport Beach, California
- Vanda Investigational Site — Andover, Massachusetts
- Vanda Investigational Site — Shelby, North Carolina
- Vanda Investigational Site — Memphis, Tennessee
- Vanda Investigational Site — Lynchburg, Virginia
📞 Contact the Study Coordinator
Phone: (202) 734-3400
Email: clinicaltrials@vandapharma.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Dry Eye
- A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months. — Glendale, California
- A Single Center, Open-Label Study to Evaluate the Ability of the TearScience™ LipiView™ II Ocular Surface Interferometer and the Keratograph® 5M to Detect Tear Film Stability Utilizing Miebo® — Louisville, Kentucky
- DOMPE -MT Neurotrophic Keratitis — Nashville, Tennessee
- Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy — Nashville, Tennessee
- Penn SICCA Follow-up Study — Philadelphia, Pennsylvania
- Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment — Berkeley, California
Explore by condition: All Dry Eye clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.